-
Oct 09, 2013Study revealed the important role of regulatory B cells in control of malaria-induced immunopathologyCerebral malaria (CM) is a neurological syndrome often occurring in human severe malaria. Although CM is known as an immunopathology in brain tissue mediated by excessive pro-inflammatory cytokines, the immunoregulatory mechanism is poor...
-
Oct 09, 2013Study revealed the important role of regulatory B cells in control of malaria-induced immunopathologyCerebral malaria (CM) is a neurological syndrome often occurring in human severe malaria. Although CM is known as an immunopathology in brain tissue mediated by excessive pro-inflammatory cytokines, the immunoregulatory mechanism is poor...
-
Jul 29, 2013The Scientists in GIBH Created Immune-deficient Rabbits by Using TALEN TechnologyRecently, a research group led by Prof. Liangxue Lai and Duanqing Pei has successfully applied transcription activator-like effector nucleases (TALENs) to rabbit gene targeting and established a high-efficiency technique platform for spe...
-
Jul 29, 2013The Scientists in GIBH Created Immune-deficient Rabbits by Using TALEN TechnologyRecently, a research group led by Prof. Liangxue Lai and Duanqing Pei has successfully applied transcription activator-like effector nucleases (TALENs) to rabbit gene targeting and established a high-efficiency technique platform for spe...
-
Jul 15, 2013GIBH’s new progress of treating clinically non-small-cell Lung cancer (NSCLC) patients with acquired resistantLung cancer is the leading cause of cancer deaths in the worldwide. Non-small-cell lung cancer (NSCLC) accounts for about 85% of all lung cancers.Small molecular inhibitors of epidermal growth factor receptor (EGFR), gefinitib and erloti...
-
Jul 15, 2013GIBH’s new progress of treating clinically non-small-cell Lung cancer (NSCLC) patients with acquired resistantLung cancer is the leading cause of cancer deaths in the worldwide. Non-small-cell lung cancer (NSCLC) accounts for about 85% of all lung cancers.Small molecular inhibitors of epidermal growth factor receptor (EGFR), gefinitib and erloti...